The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Two years ago, he was diagnosed with prostate cancer. Now he is cancer-free, and his message to men is to get checked for ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James Wasielewski would be the first patient in ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Prostate health is one of the most overlooked yet critical concerns for men over 40, yet most available solutions offer ...

Dr. Dan Sperling As a radiologist specializing in prostate cancer diagnosis and treatment, I’m writing to share a fear I often hear from my patients. “Will this treatment affect my sex life?” This ...

open-label superiority RCT that included 1,126 participants (median 66 years). The vast majority (92.7%) were white British, ...

As the name suggests, prostate cancer occurs in the prostate gland, which is located at the base of the bladder. The main function of the prostate gland, a male reproductive organ, is to secrete ...